Tirzepatide provides significant blood sugar and weight reduction in diabetics: SURPASS Trial Hina Zahid14 July 2021 11:45 AM ISTTirzepatide is delivering unprecedented results that could help millions of people with type 2 diabetes and their health care providers reach A1C and...
Liraglutide and insulin most effective in maintaining optimal blood sugar levels in diabetics: Study Medha Baranwal13 July 2021 11:00 AM ISTResults of GRADE demonstrated that liraglutide and insulin were the most effective of the four medications in keeping A1C levels less than...
Dulaglutide lowers erectile dysfunction risk in men with type 2 diabetes: Lancet Medha Baranwal12 July 2021 11:15 AM ISTCanada: The long-term use of dulaglutide, a GLP-1 receptor agonist, may reduce the risk of severe erectile dysfunction in men with type 2 diabetes,...
Bayer Finerenone gets USFDA approval to treat CKD associated with type 2 diabetes Ruchika Sharma11 July 2021 10:00 AM ISTBerlin: Bayer has announced that the U.S. Food and Drug Administration (FDA) has approved finerenone, the first non-steroidal, selective...
Efpeglenatide lowers CV and kidney disease risk in high-risk diabetes patients: Study Medha Baranwal10 July 2021 10:15 AM ISTThe cardiovascular and renal benefits occurred independently of the baseline use of SGLT2 inhibitors, the baseline use of metformin, and the baseline...
Earlier Blood sugar control in Diabetes lowers risk of death and heart attack: Study Dr. Kamal Kant Kohli9 July 2021 11:30 AM ISTEarlier blood sugar control in Diabetes type 2 patients prevents them from heart attack and death, finds a joint study from the Universities of...
Hospitalization for diabetes in children doubled during COVID-19 pandemic: Study Hina Zahid7 July 2021 9:00 AM ISTThe findings reinforces the importance of maintaining a healthy lifestyle for children even under such difficult circumstances of COVID-19...
Pulsatile insulin infusion improves kidney function, BP and patient satisfaction in diabetes: Study Dr. Nandita Mohan6 July 2021 9:00 AM ISTimprovement of kidney function, systolic blood pressure, and treatment satisfaction in patients with type 2 diabetes
Time-Restricted Eating May Reduce Diabetes-Related Hypertension: Study Hina Zahid5 July 2021 9:24 PM ISTLEXINGTON, Ky. -Time-restricted eating may be able to help people with Type 2 diabetes reduce nocturnal hypertension, which is characterized by...
SGLT2 inhibitors better than sulfonylureas for reducing deaths in type 2 diabetes: JAMA Medha Baranwal5 July 2021 11:45 AM ISTSt Louis, Missouri: The use of SGLT2 inhibitors may reduce the risk of all-cause mortality compared with sulfonylureas in patients with type 2...
Urinary podocin early marker of diabetic nephropathy in T2D, finds study Dr Satabdi Saha5 July 2021 9:00 AM ISTThe urinary podocin can serve as an early marker for diabetic nephropathy as well as a marker of disease progression and severity among...
SGLT2 inhibitors cause double weight loss than GLP-1 receptor agonists in diabetics: Study Hina Zahid3 July 2021 10:30 AM ISTAmong 72 patients, people using SGLT2 inhibitors experienced a median weight loss of more than 6 pounds, while those on GLP-1 receptor agonists lost a...
